查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611505

口服注射器市场规模、份额、趋势分析报告：按类型、按用途、按最终用途、按地区、细分市场预测，2025-2030 年

Oral Syringes Market Size, Share & Trends Analysis Report By Type, By Usage, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

口腔注射器市场成长与趋势

根据Grand View Research, Inc.最新报告，预计2030年全球口腔注射器市场规模将达10.5亿美元，2025年至2030年复合年增长率为6.1%。

推动市场成长的因素包括呼吸系统疾病盛行率的增加、儿童癌症发生率的增加、技术进步和政府措施。慢性阻塞性肺病盛行率的上升是推动市场成长的因素之一。根据世界卫生组织2024年11月发布的论文，慢性阻塞性肺病（COPD）是全球重大健康挑战，位居全球第四大死因，2021年死亡人数约350万人死亡，占全球整体的5%。这项负担在低收入和中等收入国家 (LMIC) 尤为严重，其中近 90% 的 70 岁以下慢性阻塞性肺病相关死亡发生在这些国家。慢性阻塞性肺病的治疗通常需要长期用药方案，其中包括针对吞嚥困难或需要精确剂量的患者使用液体製剂。这对确保精确和受控剂量的口腔注射器产生了巨大的需求，特别是在慢性阻塞性肺病高发地区。

儿科手术数量的增加也推动了口腔注射器市场的成长。根据 Breaking Media, Inc. 2024 年 2 月发表的报导，美国每年对儿科患者进行近 400 万例手术，凸显了儿童的高医疗需求。然而，儘管有这个数字，但针对儿科的医疗解决方案仍有差距，因为许多外科创新历来都专注于治疗成人。对以儿科为重点的医疗护理的需求不断增加，为包括口腔注射器在内的专用医疗设备创造了机会，以确保年轻患者的准确剂量，特别是在手术后的恢復期间。口服注射器能够精确输送药物，降低与剂量不当相关的风险，并支持更好的儿科护理结果。随着医疗行业专注于改善儿科护理，针对儿童需求量身定制的口服注射器的需求预计将会增加。这一趋势凸显了开发满足儿科患者独特需求的医疗解决方案以及确保术后和持续护理环境中安全有效的治疗变得越来越重要。

口服注射器市场报告亮点

  • 按类型划分，透明口服注射器细分市场占据最大份额，到 2024 年将达到 62.9%。慢性健康意识和注射器技术进步正在推动该领域的成长。
  • 按用途划分，可重复使用口服注射器市占率最大，到 2024 年将达到 50.1%。慢性病盛行率的增加和製造商提供的技术先进的产品正在推动这一领域的成长。
  • 以最终用途划分，医院领域所占份额最大，到 2024 年将达到 56.3%。这是由于医疗保健环境中对准确可靠的药物传递的需求不断增加。医院，尤其是提供儿科和新生儿护理的医院，需要高品质的口腔注射器来准确、安全地计量液体药物。
  • 2024年，北美将占据口腔注射器市场40.6%的份额。由于慢性病盛行率增加、技术进步以及儿童癌症患者数量增加等多种因素，口腔注射器产业呈现持续成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章口服注射器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 口服注射器市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 口腔注射器市场：按类型估计和趋势分析

  • 口服注射器市场：类型仪表板
  • 口服注射器市场：类型变异分析
  • 2018-2030 年口服注射器市场规模、预测与趋势分析（按类型）
  • 透明口服注射器
  • 彩色口腔注射器

第五章口服注射器市场：依使用情况、估计值和趋势分析

  • 口服注射器市场：使用仪表板
  • 口腔注射器市场：使用变化分析
  • 2018-2030 年口服注射器市场规模、预测与趋势分析（按用途）
  • 可重复使用的口腔注射器
  • 免洗口腔注射器

第六章口服注射器市场：最终用途的估计和趋势分析

  • 口服注射器市场：最终用途仪表板
  • 口服注射器市场：最终用途变化分析
  • 2018-2030 年口服注射器市场规模、预测与趋势分析（依最终用途）
  • 医院
  • 诊所
  • 居家医疗

第七章口服注射器市场：按国家、类型、应用、最终用途、地区分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 2023年主要企业市场占有率分析
    • Baxter
    • BD.
    • Medtronic
    • Terumo Medical Corporation
    • B. Braun SE
    • Thermo Fisher Scientific Inc.
    • Comar
    • CODAN
    • Neelkanth Polymer Industries
    • Changzhou Medical Appliances General Factory Co.,Ltd
Product Code: GVR-4-68038-704-9

Oral Syringes Market Growth & Trends:

The global oral syringes market size is expected to reach USD 1.05 billion by 2030, registering a CAGR of 6.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The factors driving market growth are the growing prevalence of respiratory cases, the increasing prevalence of cancer incidence among the pediatric population, technological advancements, and government initiatives. The rising prevalence of COPD diseases is one of the factors boosting market growth. According to the WHO article published in November 2024, Chronic obstructive pulmonary disease (COPD) is a major global health challenge, ranking as the fourth leading cause of death worldwide and accounting for approximately 3.5 million deaths in 2021, or 5% of all global fatalities. The burden is particularly severe in low- and middle-income countries (LMICs), where nearly 90% of COPD-related deaths in individuals under 70 years occur. Managing COPD often involves long-term medication regimens, including liquid formulations for patients who face difficulty swallowing or require precise dosing. This creates a significant demand for oral syringes, which ensure accurate and controlled administration, especially in regions with high COPD prevalence.

The rising number of surgical procedures in children drives the growth of the oral syringes market. According to a Breaking Media, Inc. article published in February 2024, nearly four million surgical procedures are performed on pediatric patients in the United States each year, highlighting the significant healthcare needs of children. However, despite this large number, much surgical innovation has historically been geared toward adult treatments, leaving a gap in pediatric-specific medical solutions. This growing demand for pediatric-focused healthcare creates an opportunity for specialized medical devices, including oral syringes, to ensure accurate medication dosing in young patients, especially during post-surgical recovery. Oral syringes allow for precise delivery of medications, reducing the risks associated with improper dosing and supporting better outcomes in pediatric care. As the healthcare industry emphasizes improving pediatric care, the demand for oral syringes tailored to children's needs is expected to rise. This trend underscores the growing importance of developing medical solutions that meet the unique requirements of pediatric patients, ensuring safe and effective treatment in the postoperative and ongoing care settings.

Oral Syringes Market Report Highlights:

  • Based on type, the clear oral syringes segment held the largest share of 62.9% in 2024. The increase in chronic health awareness and the technological advancements in syringes drive the segment's growth.
  • Based on usage, the reusable oral syringes segment held the largest share of 50.1% in 2024. The increased prevalence of chronic diseases and technologically advanced products offered by the manufacturer drive the segment's growth.
  • Based on end-use, the hospitals segment held the most significant share of 56.3% in 2024, driven by the increasing demand for precise and reliable medication delivery in healthcare settings. Hospitals, particularly those providing pediatric and neonatal care, require high-quality oral syringes for accurate dosage and safe administration of liquid medications
  • North America dominated the oral syringes market with a share of 40.6% in 2024. The oral syringes industry exhibits consistent growth owing to several factors, including the increasing prevalence of chronic diseases, technological advancements, and rising pediatric cancer cases.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Usage
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market outlook
  • 2.2. Segment outlook
    • 2.2.1. Type outlook
    • 2.2.2. Usage outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Oral Syringes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing cancer cases among pediatric population
      • 3.2.1.2. Rising respiratory cases
      • 3.2.1.3. Rising number of surgical procedures in the children
      • 3.2.1.4. Technological advancement
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost compared to dose cups and droppers
  • 3.3. Oral Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Oral Syringes Market: Type Estimates & Trend Analysis

  • 4.1. Oral Syringes Market: Type Dashboard
  • 4.2. Oral Syringes Market: Type Movement Analysis
  • 4.3. Oral Syringes Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Clear Oral Syringes
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Colorful Oral Syringes
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Oral Syringes Market: Usage Estimates & Trend Analysis

  • 5.1. Oral Syringes Market: Usage Dashboard
  • 5.2. Oral Syringes Market: Usage Movement Analysis
  • 5.3. Oral Syringes Market Size & Forecasts and Trend Analysis, by Usage, 2018 to 2030 (USD Million)
  • 5.4. Reusable Oral Syringes
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Single Use Oral Syringes
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Oral Syringes Market: End Use Estimates & Trend Analysis

  • 6.1. Oral Syringes Market: End Use Dashboard
  • 6.2. Oral Syringes Market: End Use Movement Analysis
  • 6.3. Oral Syringes Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Homecare Settings
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Oral Syringes Market: Regional Estimates & Trend Analysis by Country, Type, Usage, End-use and Region

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/ reimbursement structure
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Baxter
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. BD.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Medtronic
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Terumo Medical Corporation
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. B. Braun SE
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Thermo Fisher Scientific Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Comar
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. CODAN
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Neelkanth Polymer Industries
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Changzhou Medical Appliances General Factory Co.,Ltd
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. Global oral syringes market, by type 2018 - 2030 (USD Million)
  • Table 3. Global oral syringes market, by usage 2018 - 2030 (USD Million)
  • Table 5. Global oral syringes market, by end-use, 2018 - 2030
  • Table 6. Global oral syringes market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 9. North America oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 10. North America oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 11. U.S. oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 12. U.S. oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 13. U.S. oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 14. Canada oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 15. Canada oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 16. Canada oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 17. Mexico oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 18. Mexico oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 19. Mexico oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 20. Europe oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 21. Europe oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 22. Europe oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 23. Europe oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 24. U.K. oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 25. U.K. oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 26. U.K. oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 27. Germany oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 28. Germany oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 29. Germany oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 30. France oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 31. France oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 32. France oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 33. Italy oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 34. Italy oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 35. Italy oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 36. Spain oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 37. Spain oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 38. Spain oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 39. Denmark oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 40. Denmark oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 41. Denmark oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 42. Sweden oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 43. Sweden oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 44. Sweden oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 45. Norway oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 46. Norway oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 47. Norway oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 52. Japan oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 53. Japan oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 54. Japan oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 55. China oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 56. China oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 57. China oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 58. India oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 59. India oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 60. India oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 61. Australia oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 62. Australia oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 63. Australia oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 64. Australia oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 65. Thailand oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 66. Thailand oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 67. Thailand oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 68. South Korea oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 69. South Korea oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 70. South Korea oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 71. Latin America oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 72. Latin America oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 73. Latin America oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 74. Latin America oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 75. Brazil oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 76. Brazil oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 77. Brazil oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 78. Argentina oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 79. Argentina oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 80. Argentina oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 81. MEA oral syringes market, by country, 2018 - 2030 (USD Million)
  • Table 82. MEA oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 83. MEA oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 84. MEA oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 85. South Africa oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 86. South Africa oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 87. South Africa oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 90. Saudi Arabia oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 91. UAE oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 92. UAE oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 93. UAE oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 94. Kuwait oral syringes market, by type, 2018 - 2030 (USD Million)
  • Table 95. Kuwait oral syringes market, by usage, 2018 - 2030 (USD Million)
  • Table 96. Kuwait oral syringes market, by end-use, 2018 - 2030 (USD Million)
  • Table 97. Participant's overview
  • Table 98. Financial performance
  • Table 99. Key companies undergoing expansions
  • Table 100. Key companies undergoing acquisitions
  • Table 101. Key companies undergoing collaborations
  • Table 102. Key companies launching new product types
  • Table 103. Key companies undergoing partnerships
  • Table 104. Key companies undertaking other strategies

List of Figures

  • Fig. 1 Oral syringes market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot - I
  • Fig. 9 Segment snapshot -II
  • Fig. 10 Competitive landscape
  • Fig. 11 Oral syringes market dynamics
  • Fig. 12 Oral syringes market: PORTER's analysis
  • Fig. 13 Oral syringes market: PESTEL analysis
  • Fig. 14 Oral syringes market: Type dashboard
  • Fig. 15 Oral syringes market Type movement analysis
  • Fig. 16 Global clear oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 17 Global colorful oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 18 Oral syringes market: Usage dashboard
  • Fig. 19 Oral syringes market Usage movement analysis
  • Fig. 20 Global reusable oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 21 Global single use oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 22 Oral syringes market: End use dashboard
  • Fig. 23 Oral syringes market End use movement analysis
  • Fig. 24 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 25 Global clinics market, 2018 - 2030 (USD Million)
  • Fig. 26 Global homecare settings market, 2018 - 2030 (USD Million)
  • Fig. 27 Oral syringes market revenue, by region, 2024 & 2030, (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Canada oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Europe oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 UK oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Germany oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 France oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Italy oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Spain oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Norway oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Japan oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 China oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 India oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Australia oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 MEA oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 UAE oral syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait oral syringes market, 2018 - 2030 (USD Million)
  • Fig. 57 Heat map analysis
  • Fig. 58 Strategy mapping